Article

GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+T cells

2024-05-21

Abstract excerpt

<title>Abstract</title> <p>Bladder cancer (BC) ranks as the fourth cancer in males and the tenth most common cancer worldwide. Conventional treatment modalities, including surgery, radiation, chemotherapy, and immunotherapy, have limited efficacy in certain advanced instances. The involvement of GALNT6-mediated aberrant O-glycosylation modification in several malignancies and immune evasion is a subject of specul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ead465d8-8f86-5fd3-ad4a-099a8476960e
DOI: 10.21203/rs.3.rs-4395360/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+T cellsDOI 10.21203/rs.3.rs-4395360/v1Read

Identification of tumor antigens and immune subtypes of bladder cancer for mRNA vaccine developmentSemantic proximity Read

Bladder cancer-derived exosomal KRT6B promotes invasion and metastasis by inducing EMT and regulating the immune microenvironmentSemantic proximity Read

O-GlcNAcylation promotes malignant phenotypes of bladder cancer cells.Semantic proximity Read

Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascadeSemantic proximity Read

N‐acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progressionSemantic proximity Read

Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer.Semantic proximity Read

G-Protein Subunit Gamma 4 as a Potential Biomarker for Predicting the Response of Chemotherapy and Immunotherapy in Bladder CancerSemantic proximity Read

GRASLND is a prognostic biomarker and associated with immune infiltration in bladder cancerSemantic proximity Read

Pan-cancer analysis of the glycoprotein - associated gene B4GALNT4 with prognositc value and immunological role in malignant tumorsSemantic proximity Read

Key Cancer Glycosylation-related Genes Analysis: Regulatory, Therapeutic, and Prognostic InsightsSemantic proximity Read

Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasionSemantic proximity Read

Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancerSemantic proximity Read